Tomoaki Kobayashi, MD

Senior Researcher, Department of Global Health Metrics and Evaluation,
Bureau of Global Health Cooperation,
Japan Institute for Health Security(JIHS), Tokyo, Japan

AREA OF EXPERTISE

Cardiology
Health Economics

MESSAGE

I am conducting research to evaluate the visualization of the effects of medical interventions from the perspective of health economics. I am particularly interested in disease prevention and effect prediction using predictive models.

Narrative CV

Tomoaki Kobayashi is a Specially Appointed Researcher at the Institute for Global Health Policy Research under the Bureau of International Health Cooperation at the National Center for Global Health and Medicine in Japan. He is a cardiologist. After several years of clinical experience, he entered Osaka University Graduate School of Medicine in 2023. He is particularly interested in disease prevention and effect prediction using predictive models, and plans to conduct research to evaluate the visualization of the effects of medical intervention from the perspective of health economics.

 Detailed Curriculum Vitae

Tomoaki Kobayashi, MD
Japanese physician specializing in cardiovascular medicine and health economics. With over ten years of clinical experience, he now conducts research that visualizes the impact of medical interventions through the lens of health economics, motivated by clinical questions encountered in daily practice.

Positions

Senior Researcher, Department of Global Health Metrics and Evaluation,Bureau of Global Health Cooperation,Japan Institute for Health Security(JIHS)

Career

Selected publications

• Five-year clinical efficacy and safety of contemporary thin-strut biodegradable-polymer versus durable-polymer drug eluting stents: a systematic review and meta-analysis of 9 randomized controlled trials. Cardiovascular Intervention and Therapeutics. 2020 Jul;35(3):250-258
• Neointimal characteristics comparison between biodegradable-polymer and durable-polymer drug-eluting stents: 3-month follow-up optical coherence tomography light property analysis from the RESTORE registry: The International Journal of Cardiovascular Imaging 2020 Feb;36(2):205-215.
• Impact of off-label reduced dose of direct oral anticoagulants in combination with antiplatelet agents on clinical outcomes: A propensity score-matching analysis from the DIRECT real-world non-valvular atrial fibrillation registry: Circ Rep. 2020 Apr 7;2(6):289-296.